Statistical Issues in Interpretation of Anti-Estrogen Trials in Early Breast Cancer and a view at Ongoing Prevention Trials

Upon completion of the program, participants will be better able to:

     Recognize the key statistical issues in adjuvant anti-estrogen trials

     Be aware of recent updates in adjuvant anti-estrogen trials

     Be able to optimize adjuvant anti-estrogen strategies from a statistical perspective

     Recognize ongoing trials in chemoprevention

 

The program is available on the OncologyEducation.ca eLearning Portal: Click here to access the program.

This program was made possible through an unrestricted educational grant from Astra Zeneca.